Provided by Tiger Trade Technology Pte. Ltd.

T. Rowe Price Health Care ETF

36.41
+0.24530.68%
Volume:8K
Turnover:302.09K
Market Cap:31.86M
PE:- -
High:36.56
Open:36.30
Low:36.30
Close:36.17
52wk High:36.72
52wk Low:24.99
Shares:875.00K
Float Shares:875.00K
Volume Ratio:2.67
T/O Rate:0.95%
Dividend:0.16
Dividend Rate:0.44%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

UnitedHealth Optum CEO Patrick Hugh Conway Disposes of 1,169 Shares for $455,910

Reuters
·
11 mins ago

Sweden's BioArctic Q2 Revenue Falls Despite Higher Leqembi Royalties

Reuters
·
3 hours ago

AlzeCure Swings to Q2 FY26 Profit of SEK 80.18 Million; Net Sales Rise to SEK 97.33 Million

Reuters
·
3 hours ago

Eli Lilly (LLY) Stock Trades Below Fair Value On Cash Flow

Simply Wall St.
·
5 hours ago

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
11 hours ago

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
12 hours ago

Moderna Inc. Stock Rallies 14.4%, Outperforms Peers

Dow Jones
·
12 hours ago

Eli Lilly & Co. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
12 hours ago

Abbott Laboratories Gets Regulatory Authorization for Dual Glucose-Ketone Sensor

MT Newswires Live
·
13 hours ago

FDA Authorizes Abbott's Wearable to Monitor Ketone and Glucose in Diabetes Patients

Reuters
·
13 hours ago

Abbott receives FDA authorization for Libre Duo 10 Day system

TIPRANKS
·
14 hours ago

Abbott - to Launch Libre Duo 10 Day in U.S. Later This Year

THOMSON REUTERS
·
14 hours ago

Abbott Receives FDA Authorization for World's First Dual Glucose-Ketone Sensing Technology for People with Diabetes

THOMSON REUTERS
·
14 hours ago

Eli Lilly Stock (LLY) Rattled as Companies Decline to Cover Weight-Loss Drug Costs

TIPRANKS
·
14 hours ago

FDA Authorizes First Wearable Device That Continuously Monitors Both Ketone Levels and Blood Sugar

Reuters
·
14 hours ago

FDA :Granted Marketing Authorization to Abbott Diabetes Care for Libre Duo 10 Day Through De Novo Premarket Review Pathway

THOMSON REUTERS
·
14 hours ago

More US Employers to Drop Weight-Loss Drugs in 2027, as Healthcare Costs Increase

Reuters
·
15 hours ago

Lilly’s LY4395089 Interaction Study Marks Quiet but Important Early-Stage Progress

TIPRANKS
·
16 hours ago

FDA Greenlights Roche and Eli Lilly's Blood-Based Alzheimer's Test, Setting a Single Threshold to Rule Both In and Out Amyloid Pathology

Deep News
·
Yesterday

Moderna Inc Stock (MRNA) Moved Up by 10.02% on Aug 25: Drivers Behind the Movement

TradingKey
·
Yesterday